Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

  • STATUS
    Recruiting
  • End date
    Jan 31, 2023
  • participants needed
    6
  • sponsor
    Weill Medical College of Cornell University
Updated on 19 April 2022
somatostatin
dotatate
dotatoc

Summary

The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET and Ga-68-DOTATOC PET in patients with meningioma.

Description

The investigator is proposing a direct comparison of Ga-68-DOTATATE and -DOTATOC in a pilot cohort of patients with meningioma, and hypothesize non-inferiority of DOTATOC. This pilot study will form the basis for a subsequent prospective clinical trial and will allow us to optimize our existing imaging protocols, while developing a more cost-effective protocol.

Primary Objectives:

  • Optimize the Ga-68-DOTATATE and -DOTATOC PET protocol.
  • Compare Ga-68-DOTATATE and -DOTATOC PET in patients with meningioma.

Secondary Objectives

• Correlate Ga-68-DOTATATE and -DOTATOC PET with clinical and pathological characteristics

Details
Condition Meningioma
Treatment Ga-68- DOTATATE, Ga-68-DOTATOC
Clinical Study IdentifierNCT04298541
SponsorWeill Medical College of Cornell University
Last Modified on19 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Adult patients with clinically suspected meningioma
Patients planned for surgery - undergoing preoperative workup
No contraindications to either radiotracer

Exclusion Criteria

Age less than 18 years
Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note